MAPT and Alzheimer disease: Although there is overwhelming evidence for a pathogenic role for Aβ and tau hyperphosphorylation in AD, neuroinflammation is widely regarded as the key mechanism that actively contributes to the pathology by modulating the responses of microglia and astrocytes [38–43].